At present, we’re witnessing exciting developments with regards to novel and effective treatments for trauma and PTSD. There have been compelling results using substances like MDMA and psilocybin, and they could become absolute game changers with how we treat individual and maybe even collective suffering and trauma in the future.
My guest today, Dr. Rachel Yehuda, is the director of the Center for the Study of Psychedelic Psychotherapy and a professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai. Dr. Yehuda has researched trauma and its treatment for three decades. She has authored more than 450 published papers in the field of trauma and resilience.
Her work with populations, including military veterans and Holocaust survivors, has revealed the underlying biology of trauma and PTSD, including its intergenerational effects.
In our discussion with Dr. Yehuda, you’ll learn…
-Why the government is suddenly interested in psychedelics again…03:15
-MDMA treatment for PTSD…04:55
-Pharmacologic effects of MDMA and how it helps heal…07:30
-Effectiveness of therapeutic MDMA treatment…11:50
-How trauma affects us biologically…15:50
-Intergenerational trauma link and Intergeneration transmission…27:25
-What influenced Rachel to become a scientist…35:15
-Psilocybin for therapeutic PTSD treatment…37:05
-The importance of bullet-proof science in studying psychedelics for therapy…38:05
-Dr. Yehuda’s experience from therapeutic MDMA…44:15
-Rachel’s best practices…47:35